ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 197 filers reported holding ALKERMES PLC in Q1 2021. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,038,000 | +610.1% | 109,091 | +657.6% | 0.00% | – |
| Q4 2020 | $287,000 | +20.1% | 14,400 | 0.0% | 0.00% | – |
| Q3 2020 | $239,000 | -14.3% | 14,400 | 0.0% | 0.00% | – |
| Q2 2020 | $279,000 | +34.1% | 14,400 | 0.0% | 0.00% | – |
| Q1 2020 | $208,000 | -29.3% | 14,400 | 0.0% | 0.00% | – |
| Q4 2019 | $294,000 | -80.0% | 14,400 | -80.9% | 0.00% | -100.0% |
| Q3 2019 | $1,471,000 | +3.3% | 75,366 | +19.4% | 0.00% | +100.0% |
| Q2 2019 | $1,424,000 | -34.1% | 63,127 | +6.6% | 0.00% | -66.7% |
| Q1 2019 | $2,162,000 | +9.7% | 59,237 | -11.3% | 0.00% | +50.0% |
| Q4 2018 | $1,970,000 | -12.6% | 66,747 | +25.7% | 0.00% | -33.3% |
| Q3 2018 | $2,254,000 | -29.9% | 53,121 | -32.0% | 0.00% | -40.0% |
| Q2 2018 | $3,217,000 | -62.3% | 78,147 | -46.9% | 0.01% | -64.3% |
| Q1 2018 | $8,524,000 | -39.2% | 147,053 | -42.6% | 0.01% | -36.4% |
| Q4 2017 | $14,015,000 | +144.5% | 256,059 | +148.3% | 0.02% | +10.0% |
| Q4 2016 | $5,732,000 | -21.4% | 103,137 | -33.5% | 0.02% | -23.1% |
| Q3 2016 | $7,294,000 | -32.3% | 155,087 | -37.8% | 0.03% | -33.3% |
| Q2 2016 | $10,769,000 | -8.8% | 249,164 | -27.9% | 0.04% | -11.4% |
| Q1 2016 | $11,814,000 | -28.7% | 345,537 | +65.5% | 0.04% | -29.0% |
| Q4 2015 | $16,569,000 | -6.0% | 208,726 | -30.5% | 0.06% | -13.9% |
| Q3 2015 | $17,625,000 | -4.9% | 300,413 | +4.3% | 0.07% | +5.9% |
| Q2 2015 | $18,527,000 | +20.5% | 287,959 | +14.2% | 0.07% | +23.6% |
| Q1 2015 | $15,375,000 | -6.8% | 252,166 | -10.4% | 0.06% | -8.3% |
| Q4 2014 | $16,489,000 | +31.4% | 281,576 | -3.8% | 0.06% | +27.7% |
| Q3 2014 | $12,549,000 | +42.1% | 292,728 | +66.8% | 0.05% | +38.2% |
| Q2 2014 | $8,834,000 | +10.9% | 175,517 | -2.9% | 0.03% | +13.3% |
| Q1 2014 | $7,969,000 | -8.0% | 180,753 | -15.2% | 0.03% | -9.1% |
| Q4 2013 | $8,662,000 | +47.1% | 213,043 | +21.6% | 0.03% | +37.5% |
| Q3 2013 | $5,890,000 | -1.8% | 175,180 | -16.3% | 0.02% | -4.0% |
| Q2 2013 | $6,001,000 | -48.7% | 209,249 | -66.9% | 0.02% | -49.0% |
| Q4 2012 | $11,696,000 | – | 631,549 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |